Low intensity lasers differently induce primary human osteoblast proliferation and differentiation

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Cell Biology

Background:

• Low Level Laser Therapy (LLLT) is explored for degenerative bone diseases.
• LLLT, including low level lasers (LLL) and light emitting diodes (LEDs), acts as a cellular biomodulator.
• LLLT parameters are crucial for its effects and mechanisms, necessitating standardization.

Purpose of the Study:

• To compare the effects of LLL and LED phototherapy on human osteoblast proliferation and differentiation.
• To investigate the role of ERK signaling in LLLT-induced osteoblast proliferation.
• To analyze the impact of different LLLT spectrums and energy densities on bone metabolism markers.

Main Methods:

• Human osteoblasts were exposed to LLL and LED phototherapy at 10 and 50 J/cm².
• ERK signaling activation was assessed using Western blotting and an ERK-specific inhibitor.
• Osteogenic differentiation was evaluated via in vitro mineralization and gene expression analysis (COL1A1, SPARC) using Real-Time PCR.

Main Results:

• LLLT increased viable cells and proliferation irrespective of the source (LLL or LED).
• Red LLL (10 J/cm²) and infrared LLL (both doses) activated ERK1/2; this activation mediated LLL-induced proliferation.
• LED phototherapy upregulated both COL1A1 and SPARC gene expression, while LLL showed spectrum-specific effects on these genes. All LLLT enhanced mineralization.

Conclusions:

• LLL and LED phototherapy differentially modulate human osteoblast metabolism.
• LLLT enhances osteoblast proliferation through ERK-dependent or independent pathways.
• LLLT effectively promotes osteogenic differentiation markers, suggesting therapeutic potential for bone regeneration.